Oregon Health And Science University
Novel blood test could be first step to early detection of pancreatic cancer
A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a retrospective study.
Positive trial of ponsegromab may signal ‘start of a revolution’ for cancer cachexia
A randomized phase 2 trial of individuals with cancer cachexia showed those assigned ponsegromab gained significantly more weight than those assigned placebo.
Aficamten improves outcomes in obstructive HCM via significant cardiac remodeling
Improvements in exercise capacity and quality of life associated with aficamten coincided with significant cardiac remodeling and replacement fibrosis in patients with obstructive hypertrophic cardiomyopathy, a speaker reported.
‘Symptom science’ research effort aims to optimize quality of life, minimize toxicities
Oregon Health & Science University has implemented a “symptom science” clinical research program designed to mitigate toxicities and improve quality of life for people with cancer.
High-quality, noninvasive testing may safely diagnose CAD for patients with obesity
High-quality CT and stress testing should be able to effectively and safely diagnose patients with stable chest pain and suspected CAD, regardless of BMI, while improving clinical efficiency, researchers reported.
Osteoporosis treatment equally lowers hip fracture risk for both men and women
Osteoporosis treatment reduces the risk for hip fractures for older men just as well as it does for older women, according to a study published in Journal of Bone and Mineral Research.
All-polyethylene TKA components may decrease risk of revision vs. metal-backed components
In patients aged 65 years or older, results showed all-polyethylene tibial components for total knee arthroplasty were linked with decreased risks of all-cause revision and revision for infection compared with metal-backed components.
ASCO guideline helps clinicians address cannabis use ‘head on’ with their patients
Broader accessibility to and use of cannabis and cannabinoids has created formidable challenges for clinicians who treat people with cancer.
VIDEO: Data shed new light on treatments for acromegaly, Cushing’s disease
BOSTON — In this video exclusive, Maria Fleseriu, MD, FACE, discusses some of the top adrenal and pituitary news from ENDO 2024.
Osilodrostat improves comorbid hypertension, diabetes for adults with Cushing’s disease
BOSTON — Long-term osilodrostat therapy may improve symptoms of comorbid cardiometabolic disorders such as hypertension and diabetes for adults with Cushing’s disease, according to data presented at ENDO 2024.